<p>Local anaesthetic (LA) agents are drugs that reversibly block nerve transmission. They are used to provide anaesthesia to specific areas of the body and can also be used for analgesia.</p><p>Local anaesthetics also affect transmission in motor nerves; hence, motor weakness may occur following a local anaesthetic, depending on the site of application.</p><p>Adrenaline is added to local anaesthetics to delay absorption and thus prolong their action. The usual concentration of adrenaline added to a local anaesthetic is 1:200,000.</p><p>Local anaesthetics with adrenaline should never be used where the blood supply is by end arteries e.g. should not be used for digital nerve blocks. They are also contraindicated in intravenous regional anaesthesia (IVRA).</p><p>Commonly used LAs in our sub-region are lignocaine and bupivacaine.</p><p><strong>A. Lidocaine (Lignocaine)</strong></p><ul><li>Advantage - rapid onset of action</li><li>Duration - about 1 hour</li><li>Maximum dose of plain lidocaine - 3 mg/kg (approx. 200 mg in adult)</li><li>Maximum dose of lidocaine with adrenaline - 7 mg/kg</li><li>Lidocaine is not recommended for spinal anaesthesia</li></ul><p><strong>B. Bupivacaine</strong></p><ul><li>Advantage - long acting</li><li>Disadvantages - cardiotoxic, slow onset of action</li><li>Maximum dose is 2 mg/kg (for both plain and with adrenaline added)</li></ul><figure class="table"><table><tbody><tr><td><strong>Bupivacaine should be used with caution. Apart from general resuscitative measures, intralipid 20% is effective for the treatment of cardiotoxicity.</strong></td></tr></tbody></table></figure><p><strong>C. Ropivacaine</strong></p><ul><li>Advantage - long acting, less cardiotoxic</li><li>Maximum dose is 3 mg/kg</li></ul><p><strong>Uses of local anaesthetic agents</strong></p><ul><li>Topical</li><li>Local infiltration</li><li>Nerve blocks</li><li>Intravenous regional anaesthesia</li><li>Spinal anaesthesia (subarachnoid block)</li><li>Epidural anaesthesia/analgesia</li><li>Nebulisation for anaesthetizing upper airway</li><li>Inravenous preparation of lignocaine used as an antiarrhythmic</li></ul><p><strong>Prevention of local anaesthetic toxicity</strong></p><ul><li>Always aspirate before injecting, to prevent inadvertent intravascular injection</li><li>Do not inject large volumes at a time</li><li>Caution when injecting into areas of high vascularity</li></ul><p><strong>Symptoms and signs of local anaesthesia toxicity</strong></p><ul><li>Peri-oral tingling, tinnitus, light headedness</li><li>Visual disturbances, slurred speech</li><li>Altered consciousness, seizures, loss of consciousness, respiratory arrest</li><li>Hypotension, cardiac arrhythmias, cardiac arrest</li></ul><p><strong>Treatment of local anaesthetic toxicity</strong></p><ul><li>Stop injection of LA</li><li>Start ABC (Airway, Breathing, Circulation) of resuscitation</li><li>Give 100% oxygen. If necessary, intubate patient</li><li>Give Midazolam (3-5 mg) or diazepam (5-10 mg) to treat seizures. If seizures persist, an anaesthetist can give thiopentone 1-2 mg/kg or more midazolam and paralyse, intubate and ventilate patient</li><li>Treat cardiovascular instability with IV fluids, inotropes, and when bupivacaine or ropivacaine has been used, give Intralipid 20% using regime below</li><li>If cardiac arrest occurs, start CPR and call for help</li></ul><p><strong>Use of 20% intralipid in treatment of local anaesthetic toxicity (following bupivacaine or ropivacaine)</strong></p><ul><li>In addition to other resuscitative measures outlined above:</li><li>Give an intravenous bolus of Intralipid 20%, 1.5 ml/kg fast (approx. 100 ml for a 70kg patient)</li><li>Start an infusion of 20% Intralipid at 0.25 ml/kg/min (approx. 400 ml over 20 mins for a 70 kg patient)</li><li>Repeat initial bolus twice at 5minute intervals, if adequate circulation has not been restored</li><li>Maximum dose of 12 ml/kg of Intralipid 20% should not be exceeded</li></ul>